Loading...
Loading IPO details...
MAHALIFE
LISTEDInvestors can bid for minimum 1200 shares (2 lots min for Individual) and in multiples. The table shows min-max investment by Individual and HNI.
| Application | Lots | Shares | Amount |
|---|---|---|---|
Individual(min) | 2 | 2,400 | ₹2.74L |
Individual(max) | 2 | 2,400 | ₹2.74L |
SHNI(min) | 3 | 3,600 | ₹4.10L |
SHNI(max) | 7 | 8,400 | ₹9.58L |
BHNI(min) | 8 | 9,600 | ₹10.94L |
Note: Lot size is 1200 shares at ₹114/share (₹₹1.37L/lot). SME: 2 lots minimum. Limits: Individual ₹0-₹2L, sHNI ₹2L-₹10L, bHNI >₹10L.
Mahamaya Lifesciences Limited is a company engaged in marketing its own branded products primarily in various Indian states and exporting internationally. It has shown significant revenue and profit growth in recent years and operates through an established dealer network.
Despite good financial growth and reasonable valuation, the extremely low subscription (0.02x) shows poor market interest and weak demand. SME IPO segment risks including low liquidity and price volatility post-listing add risk. Considering these factors, it is advisable to avoid applying for this IPO for long-term investment. Interested investors may consider only if listing gains appear favorable after the listing date but should proceed cautiously.
Analyst Notes: Automated research generated via Perplexity AI